Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharmaceuticals Regulatory News (FARN)

Share Price Information for Faron Pharmaceuticals (FARN)

Share Price is delayed by 15 minutes
Get Live Data
46.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.00 (4.444%)
Market Cap: £91.78m
FARN Live PriceLast checked at - London Stock Exchange

Intraday Faron Pharmaceuticals Share Chart

Date   Source Headline
6th Feb 20257:00 amMFNResults of the Significantly Oversubscribed Placing
5th Feb 20254:30 pmMFNProposed Issue and Placing
5th Feb 20254:30 pmRNSProposed Issue and Placing
31st Jan 20257:00 amRNS-RFinal Patient Identified for BEXMAB Phase II Study
13th Dec 20247:00 amRNSFaron’s Financial Calendar for 2025
27th Nov 20247:00 amRNSPositive Phase 2 Interim Results from BEXMAB Trial
5th Nov 20247:00 amRNSShareholders’ Nomination Board
22nd Oct 20247:00 amRNSFaron’s Capital Markets Day 2024
30th Aug 20247:00 amRNSGrant of options
27th Aug 20247:00 amRNSFaron 2024 Half-Year Financial Results
27th Aug 20247:00 amRNSFDA Grants Fast Track Designation for Bexmarilimab
20th Aug 20247:00 amRNSNotice of Half-Year Financial Results
8th Aug 20247:00 amRNSAppointment of Chief Financial Officer
7th Aug 202410:00 amRNSGrant of options
6th Aug 20248:30 amRNSFaron Appoints Dr. Petri Bono as new CMO
11th Jul 20247:00 amRNSFaron Announces Positive FDA Feedback
25th Jun 20242:00 pmRNSUpdate on settlement
25th Jun 202410:30 amRNSHolding(s) in Company - Replacement
24th Jun 202412:45 pmRNSHolding(s) in Company
24th Jun 202412:45 pmRNSHolding(s) in Company
24th Jun 202412:45 pmRNSHolding(s) in Company
24th Jun 202412:45 pmRNSHolding(s) in Company
20th Jun 20241:00 pmRNSNew shares registered with Finnish Trade Register
20th Jun 20247:00 amRNSFully subscribed EUR 30.7 million share offering
5th Jun 20248:00 amRNSProposed REX Retail Offer
4th Jun 20247:00 amRNSFaron commences a share offering
20th May 20247:00 amRNSInitial positive data from Phase 2 of BEXMAB
17th May 20244:00 pmRNSIssuance of warrants
16th May 20247:05 amRNSFounders named European Inventor Award finalists
13th May 20247:00 amRNSReplacement – Board Change
30th Apr 20242:00 pmRNSUpdate on financial status
30th Apr 20241:00 pmRNSBoard Change
16th Apr 20247:00 amRNSFaron confirms plans under new leadership
15th Apr 20247:00 amRNSAppointment of Chief Financial Officer
8th Apr 20247:10 amRNSApproval of Warrant Terms and Conditions
8th Apr 20247:05 amRNSDecisions of the Board of Directors
8th Apr 20247:00 amRNSAppointment of Chief Executive Officer
5th Apr 202412:00 pmRNSResults of the Annual General Meeting
4th Apr 20247:00 amRNSAnnouncement of Placing
28th Mar 20247:00 amRNSIssue of Warrants to IPF Funding Update
26th Mar 202410:00 amRNSFaron´s Annual Report 2023
18th Mar 20247:00 amRNSAdditional Positive Data from Phase 1 of BEXMAB
14th Mar 20247:00 amRNSFaron to Host BEXMAB Webcast
13th Mar 20242:00 pmRNSNotice of Annual General Meeting 2024
13th Mar 20247:00 amRNSFinancial Statement January 1 to December 31 2023
4th Mar 20247:00 amRNSBinding commitments for convertible loans
28th Feb 20244:00 pmRNSReplacement - Update to 2024 Financial Calendar
27th Feb 20246:00 pmRNSUpdate to Faron’s Financial Calendar for 2024
21st Feb 20242:00 pmRNSContinued Negotiations Regarding Events of Default
19th Feb 202410:30 amRNSEvents of Default

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.